Privia Health Group, Inc. is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.89 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WGS | PRVA |
|---|---|---|
| Market cap | $1.61 B | $2.89 B |
| US-listed rank | #2258 | #1837 |
| Revenue (latest FY) | $427.54M | $2.12B |
| Net income (latest FY) | -$21.00M | $22.92M |
| Net margin | -4.9% | 1.1% |
| P/E (trailing FY) | - | 125.9 |
| SEC filings | 748 | 580 |
Privia Health Group, Inc. is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.89 B vs $1.61 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while Privia Health Group, Inc. reported $2.12B.
Full pages: GeneDx Holdings Corp. and Privia Health Group, Inc., or browse the full rankings.